Christopher Loose - Frequency Therapeutics CoFounder Officer

Insider

Christopher Loose is CoFounder Officer of Frequency Therapeutics
Age 42
Phone781 315-4600
Webwww.frequencytx.com

Frequency Therapeutics Management Efficiency

The company has return on total asset (ROA) of (0.425) % which means that it has lost $0.425 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9993) %, meaning that it created substantial loss on money invested by shareholders. Frequency Therapeutics' management efficiency ratios could be used to measure how well Frequency Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.
Frequency Therapeutics currently holds 42.95 M in liabilities with Debt to Equity (D/E) ratio of 0.47, which is about average as compared to similar companies. Frequency Therapeutics has a current ratio of 6.63, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Frequency Therapeutics' use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Silvia BuonamiciMonte Rosa Therapeutics
N/A
Jack GoldAbsci Corp
N/A
Nancy PecotaAdverum Biotechnologies
64
Arnold LevinePmv Pharmaceuticals
85
MBA MBAScholar Rock Holding
52
Jill HoweLineage Cell Therapeutics
49
Thomas JDAbsci Corp
N/A
William AnnettLineage Cell Therapeutics
70
Sean McClainAbsci Corp
35
Erin JDShattuck Labs
44
Owen WallaceMonte Rosa Therapeutics
55
Laurent ChardonnetPrelude Therapeutics
59
Andrew MBAShattuck Labs
40
Jonathan MSAbsci Corp
N/A
Duane BAArmata Pharmaceuticals
74
Leila MDPmv Pharmaceuticals
61
Melissa PattersonAbsci Corp
N/A
Courtney DuganOlema Pharmaceuticals
N/A
Simona KingPassage Bio
52
Casi DeYoungShattuck Labs
54
Caryn ParlavecchioScholar Rock Holding
53
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a persons innate regenerative potential to restore function. Frequency Therapeutics, Inc. was incorporated in 2014 and is headquartered in Lexington, Massachusetts. Frequency Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 72 people. Frequency Therapeutics (FREQ) is traded on NASDAQ Exchange in USA and employs 46 people.

Management Performance

Frequency Therapeutics Leadership Team

Elected by the shareholders, the Frequency Therapeutics' board of directors comprises two types of representatives: Frequency Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Frequency. The board's role is to monitor Frequency Therapeutics' management team and ensure that shareholders' interests are well served. Frequency Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Frequency Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
John LaMattina, Advisor Board
David Lucchino, President, CoFounder
James Abely, Associate Sec
Christopher Loose, CoFounder Officer
Jason Glashow, Sr Affairs
William MD, VP Medicine
Quentin McCubbin, Chief Officer
Wendy Arnold, Chief Officer
Carl LeBel, Chief Officer
Dana MD, Chief Officer

Frequency Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Frequency Therapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Frequency Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Frequency Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Frequency Therapeutics will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Microsoft could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microsoft when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microsoft - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microsoft to buy it.
The correlation of Microsoft is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microsoft moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microsoft moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microsoft can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Consideration for investing in Frequency Stock

If you are still planning to invest in Frequency Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Frequency Therapeutics' history and understand the potential risks before investing.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Transaction History
View history of all your transactions and understand their impact on performance
Content Syndication
Quickly integrate customizable finance content to your own investment portal